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that MHC class II leukocytes, including dendritic cells, infil-Transplant surgery injury recruits recipient MHC class II-posi-
trated native kidneys injured by ischemia/reperfusion injury.tive leukocytes into the kidney.
Conclusion. To our knowledge, this is the first demonstra-Background. CD4 T cells, which are stimulated by the “indi-
tion that injury to the kidney during transplantation recruitsrect pathway” of antigen-presentation, participate in rejection.
recipient MHC class II-positive leukocytes into the kidney.These T cells are sensitized by recipient major histocompatibil-
Some of these leukocytes are dendritic cells.ity complex (MHC) class II-positive leukocytes that migrate
into the transplant. Therefore, an important early step in rejec-
tion is the immigration of these recipient MHC class II-positive
leukocytes into the renal transplant. The regulation of this
Recipient major histocompatibility complex (MHC)early step is not understood. We now test the hypothesis that
class II-positive leukocytes, which immigrate into thesuch leukocytes immigrate into the renal transplant in response
to ischemic injury occurring during the transplant procedure. renal transplant, stimulate recipient alloreactive CD4 T
Methods. We transplanted Brown Norway (BN) kidneys cells via the “indirect antigen presentation pathway” [re-
into F1 Lewis/Brown Norway (L/BN) recipients. The F1 recipi- viewed in 1–3]. Unlike T cells stimulated “directly” byents are tolerant to the parental BN antigens, and any infiltra-
donor MHC class II molecules on donor “passenger”tion of recipient MHC class II-positive leukocytes results from
leukocytes, these T cells are stimulated “indirectly” byinjury occurring during transplantation surgery. In addition,
ischemia/reperfusion injury was also induced by temporarily allopeptides bound to recipient MHC class II molecules
occluding the native renal arteries for 30 minutes. Transplanted on the cell surfaces of recipient leukocytes. These T cells
kidneys and native kidneys, which suffered ischemia/reperfusion contribute to acute and chronic rejection of kidney, liver,injury, were studied by immunohistochemistry on days 3, 7, 14,
skin, and heart transplants in humans [4–8] and rodentsand 28 after surgery. Staining by the new monoclonal antibody
[9–14].(mAb) OX62 and antibodies to MHC class II identified dendritic
cells. In addition, the following monoclonal antibodies identi- Despite the importance of recipient MHC class II-posi-
fied: gamma/delta T cells, V65; B cells, OX33; cells that may tive leukocytes in initiating CD4 T cell activation via the
be macrophages, dendritic cells, or dendritic cell precursors, indirect pathway, the signals that recruit these antigen-ED1 (1) and OX62 (2); and recipient class II MHC, OX3.
presenting cells into the transplanted kidney are not com-Results. After transplantation, the serum creatinine increased
pletely understood. Two possibilities, which are not mu-to 4 mg/dl and then decreased, which was consistent with re-
versible injury during transplantation and the absence of rejec- tually exclusive, may be considered. One possibility is
tion. We found that the injury of transplantation itself resulted that these cells are recruited by cytokines, chemokines,
in the infiltration of recipient MHC class II-positive leukocytes and adhesion molecules produced during the initial re-into the transplanted kidney. This infiltrate peaked at days 7
jection of alloantigens via the “direct pathway.” Anotherto 14 after surgery. The inflammation was peritubular and
possibility is that recipient antigen-presenting cells arepatchy and involved cortex and outer medulla. Double staining
for OX62 and OX3 identified some of the infiltrating leukocytes recruited into the transplant by the response of the kid-
as dendritic cells. Other recipient leukocytes were MHC class ney to injury occurring during the transplant procedures.
II positive, ED1 positive, and OX62 negative. We also found The latter possibility is the focus of this article.
We now report two new major findings. First, we show
that the injury of transplantation is itself sufficient toKey words: dendritic cell, transplantation, ischemia, acute renal failure,
major histocompatibility complex. recruit MHC class II recipient leukocytes into the trans-
plant. We transplanted parental (BN) kidneys into Lewis/Received for publication October 14, 1997
Brown Norway F1 (L/BN) recipients. In this model,and in revised form May 21, 1999
Accepted for publication June 7, 1999 there should be no rejection because the F1 recipients
are tolerant to parental antigens, and recipient MHC 1999 by the International Society of Nephrology
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Table 2. Serum creatinine measurements after transplantation ofTable 1. Monoclonal antibodies used to identify inflammatory cells
in BN kidneys transplanted into L/BN recipients BN kidneys into L/BN recipients
Serum creatinine mg/dlMonoclonal Cells identified by
antibody monoclonal antibody Reference
Rat Day 1 Day 3 Day 7 Day 14
OX3 Lewis class II MHC—present
JGP28 3.6 1.6 0.8 Not doneonly on recipient (L/BN) cells [15]
JGP29 4.0 3.1 2.3 1.0OX6 Class II MHC—present on both
JGP30 4.4 1.6 1.6 2.0donor and recipient cells [15]
ED1 Dendritic cells and macrophages [26] Bilateral native nephrectomies were performed on the recipients at the time
of transplant surgery.OX62 An integrin or integrin like mole-
cule present on dendritic cellsa [18]
OX33 CD45RA or A/B present only on
B cells [27]
V65 Gamma/delta T cells [28]
from Serotec (Kidlington, UK). OX33 and V65 were
a OX62 is also present on gamma/delta T cells. In our experiments, OX62 from Pharmingen (San Diego, CA, USA).identified dendritic cells, since the positive cells were negative for a gamma/
delta T cell marker (V65). Other references also indicate that OX62 cells are
dendritic cells [19–25] Renal transplantation
Male BN kidneys were transplanted into male L/BN
recipients. Donors and recipients were anesthetized with
class II leukocytes are identified by virtue of a mono- intraperitoneal pentobarbital. The donor kidneys were
clonal antibodies specific for recipient class II MHC harvested with a cuff of aorta and vena cava and perfused
(OX3) [15]. Our experiments demonstrate that the in- with 3 ml of cold (48C) University of Wisconsin (UW)
creased number of MHC class II leukocytes result from solution. End to side anastomoses of donor aorta and
injury, not alloreactivity, and from the immigration of vena cava to recipient aorta and vena cava were per-
recipient leukocytes, not from the proliferation and dif- formed. The donor ureter was anastomosed to the dome
ferentiation of donor leukocytes resident in the trans- of the recipient bladder. Unilateral native nephrectomies
plant. To our knowledge, this is the first demonstration were performed in the recipients The transplants were
that injury, occurring during transplantation, recruits re- initially divided into two equal groups to determine the
cipient MHC class II leukocytes into the transplanted effects of overnight cold storage. One group of kidneys
kidney. Although others have shown increased MHC was transplanted immediately after harvest. The average
class II-positive cells after temporarily clamping the renal vascular anastomosis time was 20 to 30 minutes, and the
artery of native kidneys [16, 17], these experiments do renal allograft was covered with saline ice during most
not exactly mimic the injury of transplantation, nor do they of this time. The other group of kidneys was stored in
exclude the possibility that the MHC class II-positive UW solution at 48C for 20 hours prior to transplantation.
leukocytes resulted from the differentiation and prolifer- We found no difference in the immunohistochemical
ation of MHC class II-negative precursors already resid- studies of these two groups of transplants, and the data
ing in the kidney. Second, we examined the transplanted analysis considers all of the kidneys as a single group. An
kidneys by double staining with monoclonal antibodies additional three delayed recipients had bilateral native
specific for recipient MHC class II and also specific for
nephrectomies at the time of transplantation in orderdendritic cells (OX62) [18–25]. We found that at days 7
to evaluate renal allograft function with serial serumand 14, some of the infiltrating cells were recipient den-
creatinines (Table 2).dritic cells. In addition, there were a number of OX62-
negative, recipient MHC class II-positive, and ED1-posi- Renal ischemia/reperfusion injury
tive cells. These may have been recipient OX62-negative
To study the effects of renal ischemia, as opposed todendritic cells, their precursors, or macrophages.
renal transplantation, male L/BN rats were anesthetized
with intraperitoneal pentobarbital, and the right native
METHODS renal artery was temporarily occluded with a vascular
Animals clamp for 30 minutes. The left kidney was used as a control.
Male BN and L/BN rats (Harlan Sprague Dawley,
ImmunohistologyHouston, TX, USA) were maintained according to guide-
Transplanted kidneys and native control kidneys werelines of the National Institutes of Health and the Univer-
harvested at day 3, 7, 14, and 28 post-transplant. Ischemicsity of Texas Southwestern Medical Center Institutional
and nonischemic L/BN kidneys were harvested at dayAnimal Care and Research Advisory Committee.
14 only. Transplanted kidneys and the native control
Antibodies kidneys were perfused via the recipient aorta with 25
ml of heparinized saline (10 units heparin/ml) using aWe used murine antirat monoclonal antibodies shown
in Table 1. OX3, OX6, ED1, and OX62 were purchased perfusion pump. This removed any contaminating donor
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blood from the vasculature of the kidney. Ischemic kid- tive) were graded for each kidney. As discussed earlier
in this article, the average grade for each kidney wasneys and their nonischemic controls were not perfused.
Each kidney was removed and sectioned transversely. used as a single data point. The data were analyzed with
analysis of variance on ranks using the software programOne section was snap frozen in OCT compound, and
the other section was fixed in paraformaldehyde-lysine- Sigma Stat. A P value of , 0.05 was considered statisti-
cally significant.periodate (PLP) for four hours, followed by 7% sucrose
in phosphate-buffered saline (PBS) overnight and then
Determination of the percentage of recipient dendriticsnap frozen in OCT compound.
cells in double stained sectionsEight micron sections of each kidney were cut on a
cryostat and placed on glass slides and air dried. The The total number of OX62 staining cells (blue) and
the number of cells double staining for both OX3 andsections were air dried and fixed in cold ethanol for 10
minutes. Sections were treated with avidin and biotin to OX62 (blue and brown) were determined in nine high-
power fields of each kidney section at days 3, 7, andblock endogenous biotin. Primary antibodies are listed
in Table 1. Tissue sections were incubated with primary 14. The ratio of double-stained cells (recipient dendritic
cells) to single blue-staining cells (total dendritic cells)antibody for 60 minutes and biotinylated horse anti-
mouse secondary antibody (Vector Laboratories, Bur- was calculated for each kidney and used as a single data
point for each time point. The day 7 and 14 data werelingame, CA, USA) for 60 minutes. Endogenous peroxi-
dase was blocked with 0.5% H2O2 in methanol for five compared with day 3 data for statistical significance.
minutes. The slides were incubated in an avidin-biotin
horseradish peroxidase complex (ABC peroxidase; Vec-
RESULTS
tor Laboratories) for 60 minutes. The color was developed
BN kidney transplants not rejected by F1with DAB (Vector Laboratories). Nuclei were counter-
(L/BN) recipientsstained with Gill’s hematoxylin (Fisher, Pittsburgh, PA,
USA). The slides were dehydrated in ethanol, cleared The F1 (L/BN) recipient was tolerant to the parental
BN renal transplant. The absence of rejection was mani-in xylene, and mounted with Permount. Tissues fixed in
PLP were treated identically except that the eight micron fested as a continued decrease in the serum creatinine
of recipients that had bilateral nephrectomies at the timesections were fixed in PLP instead of ethanol. All cell
counts were done on fresh frozen tissue. Grading of of transplantation (Table 2). Also consistent with the
absence of rejection was the decreasing inflammation intubular MHC class II (OX6) was done on PLP-fixed
tissue because the better morphology using this fixation the transplanted kidneys by 28 days, as discussed later
in this article.allowed a differentiation between interstitial and renal
tubular cells.
Recipient dendritic cells immigrate into theDouble staining of sections was performed on trans-
transplanted kidneysplant tissue from days 3, 7, and 14. Fresh frozen tissue
was again cut in eight micron sections and fixed in cold Figure 1 shows the time course of the appearance and
then the disappearance of OX62-positive cells in theethanol. The first primary antibody was OX62. The sec-
ondary antibody was the same as described earlier in transplanted kidney. We used OX62 to show immigra-
tion of dendritic cells into the transplanted kidney [18,this article. The avidin-biotin-complex was ABC phos-
phatase (Vector Laboratories) and the color was devel- 29]. Although OX62 also stains gamma-delta T cells, we
found no gamma-delta T cells in the kidney. At day 14,oped with Vector Blue (Vector Laboratories). Levami-
sole was used to block endogenous phosphatase. The when the number of OX62-positive cells peaked (Fig.
1), we found that none of the OX62-positive cells stainedsame sections were stained with the second antibody
using the technique described earlier in this article for with the monoclonal antibody V65, which detects such
gamma-delta T cells [28]. As a positive control, we didsingle staining. The second primary antibodies were ei-
ther OX6 or OX3. The nuclei were counterstained with find V65 1 cells in the spleen, which does contain gamma
delta T cells (Fig. 2) [28]. A number of laboratoriesmethyl green instead of hematoxylin.
[19–25] have confirmed the original report [18] that
Cell counting and grading OX62 is a marker of dendritic cells. As further confirma-
tion that OX62 was detecting dendritic cells, double im-For each antibody, a blinded observer counted the
number of cells per high-power field (340 objective), munostaining indicated that the OX62-positive cells
were also positive for MHC class II, which is anotherwhich were evenly distributed throughout the cortex.
The average number of cells per high power field in a marker of dendritic cells (Fig. 3) [29].
As shown in Figure 1, we found small numbers ofsingle kidney was used as a single data point in the
graphs. Tubular staining was graded on a scale of 0 to OX62-positive dendritic cells on day 3 after transplant.
These increased at day 7, peaked at day 14, and then3 instead of counted. Nine low power fields (3100 objec-
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Fig. 2. Renal and splenic staining with the monocolonal antibody V65. V65 is a monoclonal antibody that identifies gamma delta T cells. (A)
Negative staining of a donor kidney harvested at day 14 (BN donor, L/BN recipient). The white arrow shows negatively staining inflammatory
cells and “g” labels a glomerulus. (B) Positive staining in a L/BN spleen. The arrowhead shows a splenic arteriole and the arrow shows some of
the gamma delta T cell that stains positive (red) for V65. Ethanol fixation, vector red staining, hematoxylin counterstain.
no increase in dendritic cells in these kidneys compared
with kidneys taken from unmanipulated rats. This indi-
cates that the laporatomy itself did not cause dendritic
cell immigration into the kidney. We did find small base-
line numbers of dendritic cells in these control kidneys
as previously reported [30–33].
The OX62-positive dendritic cells found in the trans-
planted kidneys could be derived from OX62-negative
precursor cells from the donor (“passenger leukocytes”),
or they could have immigrated from the recipient. To
determine the origin of these dendritic cells, we double
stained sections from 11 transplanted kidneys for both
OX3 (recipient class II MHC) and OX62 (dendritic cell)
at days 3, 7, and 14. Cells that double stained were recipi-
ent dendritic cells. By counting the number of double-
staining cells per high-power field and dividing by the
total number of dendritic cells per high-power field, we
determined the percentage of recipient dendritic cells.
As shown in Table 3, at day 3, 43% of the dendritic cells
double stained with recipient-specific OX3 and dendritic-
Fig. 1. Quantitative summary of OX62-positive dendritic cells in trans-
cell specific OX62. At days 7 and 14, the percentage ofplanted kidneys. OX62 is a monoclonal antibody that is specific for
dendritic cells and gamma delta T cells. Because gamma delta T-cell these recipient dendritic cells had increased to 93 and
staining was not detected with the monoclonal antibody V65 (data not 94%, respectively. Sections were also double stained with
shown), OX62 in our experiments detects dendritic cells. The x-axis is
both OX62 and OX6 (a monoclonal antibody that de-the post-transplant day and the y-axis is the number of cells that stained
positively per high-power field (3400). Each circle or triangle represents tects both recipient and donor class II MHC) and showed
a data point for an individual kidney and is the average count for nine that all OX62-positive dendritic cells were also class II
high-powered fields. The open circles represent kidneys transplanted
MHC positive. Representative photomicrographs areimmediately; the triangles represent kidneys transplanted after over-
night storage in UW solution. The bars and lines represent the average shown in Figure 3. In all panels of Figure 3, the blue
and standard error, respectively, for pooled immediate and stored stained cells represent OX62 (dendritic cells), and thegroups of kidneys at each time point. The controls were the native
green is the counterstained nuclei (methyl green). TheL/BN kidneys harvested with the transplanted kidneys (N 5 16 for the
controls, N 5 4 for each transplant group). *P , 0.05 vs. corresponding brown staining is either recipient class II MHC (OX3;
controls. Fig. 3 A, B) or both recipient and donor class II MHC
(OX6; Fig. 3 C, D). At day 3, there were few dendritic
cells, and many of these were from the donor. Serial
sections show that they were negative for OX3 (Fig. 3A,decreased toward baseline by day 28. Note that each
single arrow) and positive for OX6 (Fig. 3C, doublecircle or triangle on the graph represents a single rat and
arrowhead). At day 7, all the dendritic cells double stainis the average cell count from nine high-powered fields
with the recipient specific class II MHC marker (OX3;taken from the cortex and outer medulla. In all our
Fig. 3B, double arrows). Note that the dendritic cell infil-graphs, the solid triangles represent kidneys transplanted
trate was interstitial and did not involve the glomeruli.after overnight storage in cold UW solution, and the
open circles represent kidneys transplanted immediately.
Infiltration of recipient MHC class II-positive,Because there was no significant difference between
OX62-negative cells into the transplanted kidneysthese groups, the data from all kidneys at a given time
We now discuss these cells in greater detail. The timeafter transplantation were pooled; the bars represent the
course of infiltration of recipient class II MHC (OX3)-means and standard errors of these pooled kidneys. As
positive cells is summarized in semiquantitative fashioncontrols, we used the right native kidney of the recipient,
in Figure 4. There was a mild infiltrate at day 3 followedwhich was not removed, and was examined for dendritic
cells on days 3, 7, 14, and 28 after transplant. We found by a heavy infiltrate at day 7. The infiltrate had declined
Fig. 3. High-power photomicrographs showing
the origin of dendritic cells in the transplanted
Brown Norway (BN) kidney by double-staining
immunohistochemistry. Table 3 shows a quantita-
tive summary. (A and C) Serial sections taken at
day 3. (B and D) Serial sections taken at day 7.
(A and B) Double stained with OX62 and OX3.
(C and D) Double stained with OX62 and OX6.
OX62 (dendritic cells) stains blue in all panels.
OX3 (recipient class II MHC) stains brown in (A
and B). OX6 (both recipient and donor class II
MHC) stains brown in (C and D). Nuclei stain
green (methyl green) in all panels. The single
arrow in (A) shows a dendritic cell that is OX62
positive but OX3 negative. The double arrows in
(B) show a dendritic cell that is both OX62 and
OX3 positive. The double arrowheads in (C and
D) show dendritic cells that are both OX62
and OX6 positive (original magnification 3400).
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Table 3. Recipient dendritic cells immigrate into the renal transplant
Day after transplantation
Day 3 Day 7 Day 14
Ratioa of recipient dendritic cells
to total dendritic cells
(recipient plus donor) 0.43 0.93 0.94
Number of transplanted BN
kidneys 4 4 3
P value compared to day 3 — 0.00002 0.0007
Transplanted kidney sections at days 3, 7, and 14 were double stained with
OX3 and OX62. Double stained cells were counted as recipient dendritic cells
and compared to the total number of OX62 positive dendritic cells. See Figure
3 for photomicrographs of double-stained kidney sections.
aRatio 5
Recipient dendritic cells
All dendritic cells
5
Number of cells double staining for both OX3 as well as OX62
Total number of OX62 positive cells
by day 28. We also stained the kidneys for ED1. Although
ED1 is often considered a marker for macrophages [26],
it is also found on some dendritic cells [34]. The time
Fig. 4. Quantitative summary of recipient (L/BN) class II major histo-course of infiltration of ED1 cells is shown in Figure 5
compatibility complex (MHC)-positive infiltrating cells in the trans-and is similar to that of recipient MHC class II-positive planted BN kidneys. OX3 is a monoclonal antibody that binds to recipi-
cells. Although B cells may be class II MHC positive, B ent class II MHC, but not donor class II MHC. Each circle or triangle
represents a data point for an individual kidney and is the average countcell (OX33) staining was absent at day 3 and barely
for nine high-powered fields: (s) kidneys transplanted immediately; (m)detectable at days 7, 14, and 28 (data not shown). kidneys transplanted after overnight storage in UW solution. The bars
We compared the staining of OX62 (dendritic cells), and lines represent the average and standard error, respectively, for
pooled immediate and stored groups of kidneys at each time point. TheED1 (macrophages and dendritic cells), OX3 (recipient
controls were the native L/BN kidneys harvested with the transplantedclass II MHC), and OX6 (recipient and donor class II kidneys (N 5 16 for the controls, N 5 4 for each transplant group).
MHC) in serial sections from a kidney at day 14, the *P , 0.05 vs. control group. Figure 6C shows a representative photomi-
crograph at day 14.time of maximal inflammation (Fig. 6). OX62 appeared
to stain a subset of the ED1-positive cells. Many of the
ED1-positive cells were also OX3 positive.
Altogether our data indicate that there are many kidneys [16, 17]. Consistent with previous reports, we
OX62-negative, recipient MHC class II-positive, ED1- did find some low-level staining of class II MHC on
positive cells in the transplanted kidney. We cannot de- control tubules [35].
termine if these are macrophages, OX62-negative den-
Dendritic cells and macrophages are increased indritic cells, or dendritic cell precursors. These cells are
native kidneys injured by ischemia/reperfusionclosely related and have common precursors [34].
One explanation for the increased macrophages and
Class II MHC on renal tubular cells in the dendritic cells in these transplanted kidneys is that ische-
transplanted kidneys mia/reperfusion injury recruited these inflammatory
cells. To test this hypothesis, we temporarily occludedWe found increased class II MHC on renal tubular
the right native renal artery of L/BN rats for 30 minutes;cells after transplantation. Figure 6D shows that OX6,
the left renal artery was not manipulated. Table 4 showswhich detects class II MHC of both the donor and the
that there were increased numbers of inflammatory cellsrecipient, stains both the donor renal tubule cells as
in the right native kidney 14 days after the ischemia/well as the recipient interstitial inflammatory cells. In
reperfusion injury. The infiltrate included cells that werecontrast, OX3 detects recipient class II MHC and stains
class II MHC-positive, ED1-positive (macrophages andonly the recipient inflammatory cells (Fig. 6C). The inter-
dendritic cells), and OX62 positive (dendritic cells).stitial staining was ignored when we graded the tubular
staining for the graph in Figure 7. The staining was quan-
DISCUSSIONtitated by grading because of the difficulty in counting
individual renal tubular cells. The increased tubular class The data in this article make two new points. First,
II MHC may be a response to ischemic injury because we show that the injury of transplantation itself is suffi-
cient to recruit MHC class II-positive recipient leukocytesit also occurs after clamping the renal artery of native
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leukocytes found in the kidney transplant are not due
to rejection. Indeed, the improving renal function after
transplant (Table 2) and the decreasing numbers of leu-
kocytes in the transplanted kidneys after two weeks
(Figs. 1, 4, and 5) are consistent with the absence of
rejection. The MHC class II leukocytes are from the
recipient because they react with the monoclonal anti-
body OX3, which detects only recipient MHC class II
[15]. We also analyzed native kidneys after temporary
clamping of the native renal artery (Table 4) and found
an increased number of MHC class II-positive leuko-
cytes. These data are consistent with that reported by
others who also examined MHC class II-positive leuko-
cytes after clamping the native renal artery [16, 17, 36].
The peak infiltration of recipient MHC class II-posi-
tive cells is 7 to 14 days after transplant in a strain combi-
nation in which there is no rejection, and the immigration
of these leukocytes into the kidney is due only to injury
(Fig. 4). However, if the recipient is not tolerant to the
donor, acute rejection may start prior to this time. There
are two explanations of the apparent paradox of acute
rejection occurring before the peak infiltration of recipi-
Fig. 5. Quantitative summary of ED1-positive cells in the transplanted ent MHC class II-positive leukocytes in response to the
kidneys. ED1 is a monoclonal antibody that binds to dendritic cells and injury of transplant. First, the vigor and tempo of the
mature macrophages. Each circle or triangle represents a data point
infiltration of these leukocytes may be increased whenfor an individual kidney and is the average count for nine high-powered
fields: (s) kidneys transplanted immediately; (m) kidneys transplanted recruitment is due both to the cytokines and chemokines
after overnight storage in UW solution. The bars and lines represent released during the initial rejection of alloantigens of
the average and standard error, respectively, for pooled immediate and
the “direct pathway” in addition to the injury of trans-stored groups of kidneys at each time point. The controls were the
native L/BN kidneys harvested with the transplanted kidneys (N 5 16 plantation. Alternatively, the immigration of recipient
for the controls, N 5 4 for each transplant group). Figure 6B shows a MHC class II-positive cells may be late, and the acute
representative photomicrograph.
rejection mediated by T cells, which are activated by
these cells via indirect pathway, occurs later—after the
first month. Thus, early acute rejection may involve CD4
T cells stimulated by the direct antigen-presentation
into the kidney in a model in which there is no rejection. pathway, whereas later acute rejection may result from
To our knowledge, this is the first demonstration that CD4 T cells stimulated by the indirect pathway. This
injury itself recruits these leukocytes into the trans- occurs in rodent models of transplantation [9, 37]. This
planted kidney. Second, we show that some of these hypothesis is also consistent with clinical observations
recipient leukocytes may be dendritic cells because they that late acute rejection (7 to 12 months after transplant)
are positive for MHC class II and for OX62. These two has a different prognosis than early acute rejection [38]
findings are discussed in greater detail in this section. and that human lymphocyte antigen-DR (HLA-DR) dis-
The injury of transplantation itself is sufficient to re- parities between donor and recipient, which would result
cruit MHC class II-positive recipient leukocytes into the in antigen presentation via the direct pathway, have less
transplant. Such leukocytes may activate recipient T cells prognostic significance after the first six months post-
via the indirect pathway of antigen presentation. They transplant [39, 40].
might be recruited into the transplant by cytokines, che- Some of the previously mentioned recipient MHC
mokines, and adhesion molecules produced during the class II-positive leukocytes are dendritic cells. Some of
initial rejection of alloantigens via the “direct pathway.” the recipient MHC class II-positive cells had surface
In addition, these leukocytes may also be recruited into markers consistent with their being dendritic cells. Dou-
the transplant by the signal generated by the kidney ble staining indicated that some cells were positive for
in response to injury occurring during the transplant two dendritic cell antigens: recipient MHC class II and
procedure. Our experiments were designed to test the OX62 (Fig. 3 and Table 3). The OX62 positivity suggests
latter possibility. In our model, the L/BN recipients that these cells are dendritic cells. Although OX62 is
should be tolerant of the transplanted parental BN kid- found on dendritic cells and gamma-delta T cells [18],
we found that our OX62-positive cells were negative forneys. The increased numbers of recipient MHC class II
Fig. 6. Serial sections of a transplant kidney harvested at day 14. (A) OX62-positive dendritic cells. (B) ED1-positive macrophages and dendritic
cells. (C) OX3-positive recipient-specific class II MHC staining. OX3 stains only interstitial cells (arrowhead indicates examples). A glomerulus
is labeled with “g,” and an arteriole is labeled with “art.” D, OX6-positive class II MHC of donor and recipient. OX6 stains interstitial and tubular
cells. The arrow indicates one such tubule. Sections were fixed in PLP and immunostained, and the color was developed with DAB (brown). The
nuclei are counterstained blue with hematoxylin. The original magnification was 3200. (Publication of this figure in color was made possible by
a grant from Fujisawa USA, Inc., Deerfield, IL.)
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Table 4. Quantitative measurement of cellular infiltrates in
ischemic native kidneys
EDI 1
OX6 1 OX62 1 dendritic cells or
MHC II dendritic cell macrophages
Control 2160.4 0.560.2 5.5 61.3
L/BN ischemic kidneys 16368.3 5.2 61.5 35 68.8
P value 0.003 0.04 0.03
L/BN kidneys were temporarily clamped for 30 minutes and harvested at day
14. The indicated antibodies were used to stain kidney sections. The control
kidneys were contralateral nonischemic kidneys. The numbers represent the
average number of cells per high power field for three kidneys. The P values
were calculated with a t-test comparing the ischemic kidneys to the control
kidneys. There were 4 kidneys in each group.
Either recipient MHC class II-positive macrophages
[43] or dendritic cells would be capable of stimulating
CD4 T cells and thus contribute to the indirect pathway
of antigen presentation. Increased numbers of dendritic
cells may be found after tissue injury [44]. Some authors
have suggested that dendritic cells are particularly potent
antigen-presenting cells to naive T cells [29, 45]. Although
the sensitization of naive T cells might occur in the trans-
Fig. 7. Semiquantitative summary of tubular staining for class II MHC plant, some studies suggest that major sites of sensitiza-
by OX6 in transplanted kidneys. OX6 binds to class II MHC of both tion are the lymph node and spleen; sensitized T cellsthe donor and the recipient. The graph is similar to Figure 1 except
then migrate into the transplant [46–49]. Dendritic cellsthat the Y-axis is the average grade of tubular staining instead of cells
per high-power field. Interstitial staining was ignored during grading. might participate in such sensitization by virtue of their
Each circle or triangle represents a data point for an individual kidney ability to ingest alloantigen in the transplant and thenand is the average count for nine high-powered fields: (s) kidneys
migrate to the lymph node and spleen [29, 45, 50].transplanted immediately; (m) kidneys transplanted after overnight
storage in UW solution. The bars and lines represent the average and All renal allografts suffer some unavoidable injury
standard error, respectively, for pooled immediate and stored groups during transplantation. This includes injury during organof kidneys at each time point. The controls were the native L/BN
harvesting, injury during cold storage and transport ofkidneys harvested with the transplanted kidneys (N 5 16 for the con-
trols, N 5 4 for each transplant group). Figure 6D shows a representa- the kidney, and injury during surgical creation of the
tive photomicrograph. vascular anastomoses between allograft and recipient.
Cadaveric allografts also are injured by the hemody-
namic instability associated with the trauma or acute
illness that caused brain death of the donor. A growing
body of data suggests the response to this injury [51–56]V65 [28], a monoclonal antibody that detects gamma-
delta T cells (Fig. 2). Furthermore, an increasing litera- or the cytokine and autonomic “storm” associated with
brain death (abstract; van der Heovon et al, Transplanta-ture indicates that cells that are OX62 positive behave
in a manner consistent with their being dendritic cells tion 65:95, 1998) [57, 58] may play a critical role in initiat-
ing allograft rejection. In other words, activation of an[19–25, 41].
Many of the recipient MHC class II-positive cells in immune response, such as allograft rejection, requires
not only recognition of non-self–antigen, but also tissuethe transplanted kidneys were OX62 negative. Although
B cells are MHC class II positive, few of these were injury [59]. According to this hypothesis, the immune
system evolved not to respond to non-self–antigensfound in the transplant. Instead, Figure 6 indicates that
many of the MHC class II-positive, OX62-negative cells alone, but to non-self–antigens that cause injury. Ordi-
narily, such non-self–antigens would be pathogens thatwere ED1 positive. ED1 is a marker of both macro-
phages and dendritic cells [26]. Early during their differ- injure tissues during the process of infection. In the case
of transplantation, the non-self–antigen would be theentiation, dendritic cells may be OX62 negative [22].
Thus, the recipient MHC class II-positive, OX62-nega- alloantigens of the allograft, and tissue injury would re-
sult from the transplant process.tive, ED1-positive cells may be macrophages, dendritic
cells, or precursors destined to differentiate into OX62- To our knowledge, this is the first report that injury
occurring to the kidney during transplantation itself re-positive dendritic cells [22]. In any event, macrophages
and dendritic cells are closely related, as they differenti- cruits recipient MHC class II-positive leukocytes into
the transplant in a model in which there is no rejection.ate from a common precursor [29, 42].
Penfield et al: Ischemic renal injury and MHC class II-positive leukocytes1768
compatibility complex antigens are potent inducers of CD41 andThese leukocytes may activate CD4 T cells via the indi-
CD81 T cell and B cell responses after cardiac allograft rejection.
rect pathway. Some of these leukocytes have cell surface Transplantation 59:401–410, 1995
12. Terness P, Dufter C, Otto G, Opelz G: Allograft survival follow-markers—class II MHC and OX62—suggesting that they
ing immunization with membrane-bound or soluble peptide MHCare recipient dendritic cells. This leukocyte population
class I donor antigens: Factors relevant for the induction of rejec-
also includes cells that are recipient class II MHC posi- tion by indirect recognition. Transpl Int 9:2–8, 1996
13. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss Htive, ED1 positive, and OX62 negative. These may be
Jr: Indirect recognition by helper cells can induce donor-specificrecipient macrophages, dendritic cells, or cells destined
cytotoxic T lymphocytes in vivo. J Exp Med 179:865–872, 1994
to differentiate into OX62-positive dendritic cells. 14. Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ,
Glimcher L: The role of “indirect” recognition in initiating rejec-
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